Pharma and Biotech
Competitors: | Okyo Pharma Limited , Hemogenyx Pharmaceuticals |
Executive Director: | Daniel Gooding |
Independent Non-Executive Director: | Madeleine Kennedy |
Non-Executive Chairman: | Julian Gilbert |
Non-Executive Dir: |
Address: | 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
Phone: | +44 (0)1223 627222 |
Website: | https://nuformix.com/ |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BYW79Y38 |
Currency | UK Pounds |
Share Price | 0.19p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 0.40 |
52 Week Low | 0.18 |
Volume | 4,560,885 |
Shares Issued | 819.31m |
Market Cap | £1.56m |
RiskGrade | 322 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:30 | 817,701 @ 0.18p |
14:30 | 842,105 @ 0.18p |
11:11 | 713,362 @ 0.19p |
11:10 | 736,842 @ 0.18p |
08:58 | 713,362 @ 0.19p |
You are here: research